@article{ATM24550,
author = {Robert Pirker},
title = {Systemic therapy of elderly patients with advanced non-small cell lung cancer—individualized treatment is key},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 1},
year = {2019},
keywords = {},
abstract = {Approximately 2.1 million individuals are diagnosed with lung cancer worldwide every year. Non-small cell lung cancer (NSCLC) comprises 80−85% of these cancers. About 40% of patients with NSCLC present with advanced disease at the time of initial diagnosis and receive palliative therapy. Patients without documented driver mutations in their cancers receive first-line chemotherapy with platinum-based doublets.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/24550}
}